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NC-ND license (http://creativecommoBackground: Intrauterine growth retardation (IUGR) is associated with reduced lung function
during infancy and perhaps throughout adulthood. The retinoic acid (RA) signaling pathway
modulates pre- and postnatal lung development. This study was conducted to test our hypoth-
esis that uteroplacental insufficiency alters the elements of the retinoid pathway in developing
lungs.
Methods: On Gestation Day 18, either uteroplacental insufficiency was induced through bilat-
eral uterine vessel ligation (IUGR group) or sham surgery (control group) was performed. Lung
tissues from the offspring were examined through Western blotting, immunohistochemistry,
and morphometry on Postnatal Day 3 and Postnatal Day 7.
Results: Compared with control rats, the IUGR rats exhibited significantly lower body weights
on Postnatal Day 3 and Postnatal Day 7 and significantly lower lung weights on Postnatal Day 3.
Uteroplacental insufficiency significantly increased RA receptor (RAR)-b protein expression on
Postnatal Day 3. The expression of RAR-a, RAR-g, cellular RA-binding protein-1, and cellular
RA-binding protein-2 between the control and IUGR rats was comparable on Postnatal Day 3
and Postnatal Day 7. Compared with the control rats, the IUGR rats exhibited a significantly
higher volume fraction of alveolar airspace on Postnatal Day 3 and Postnatal Day 7 and a signif-
icantly lower volume fraction of alveolar walls on Postnatal Day 3.of Pediatrics, Taipei Medical University Hospital, 252 Wu-Hsing Street, Taipei 110, Taiwan.
.tw (C.-M. Chen).
016.03.003
ediatric Association. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-
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creases in RAR-b expression in the lungs of newborn rats. The retinoid pathway may be one
of the probable pathways mediating lung abnormalities caused by uteroplacental insufficiency.
Copyright ª 2016, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Recent evidence suggests that adverse environments
detrimentally affect the lungs during fetal development,
resulting in persistent changes in lung structure and
compromised respiratory function during postnatal life.1
Intrauterine growth retardation (IUGR) is associated with
reduced lung function during infancy and perhaps
throughout adulthood.2,3 Alterations in fetal nutritional
status may cause developmental adaptations, permanently
changing the structure and physiology of offspring, thus
predisposing them to pulmonary diseases in adulthood.4
Uteroplacental insufficiencydaffecting w10% of human
pregnanciesdis the most common cause of IUGR.5 It is
characterized by reduced placental function and compro-
mised nutrient and oxygen delivery to the fetus.6 Similar to
humans, uteroplacental insufficiency caused by bilateral
uterine vessel ligation in pregnant rats can lead to IUGR in
rat fetuses.7 The mechanisms of lung abnormalities among
children born with IUGR require further clarification.
Retinoic acid (RA) is produced during vitamin A meta-
bolism, which involves successive oxidative reactions of
dietary precursors including retinyl esters and carotenoids.8
Morphological studies have demonstrated that RA signaling
is essential for lung development.9 The cells of developing
embryos obtain RA through the blood, where it circulates as
retinol bound to an RA-binding protein. In the cytoplasm,
retinol binds to cellular RA-binding proteins (CRABPs),
which facilitate its enzymatic conversion to RA. RA enters
the cell nucleus and activates transcription by binding to
two classes of transcription factorsdRA receptors (RARs)
and retinoic X receptors. Retinoids are crucial mediators of
prenatal and postnatal lung development.10e12 A recent
animal study demonstrated that alveolar formation and
regeneration can be rescued using postnatal RA treatment
in calorie-restricted developing rat lungs.13 In a human
study, vitamin A supplementation reduced the incidence of
bronchopulmonary dysplasia in extremely low-birth weight
infants.14 Thus, we hypothesized that uteroplacental
insufficiency alters the elements of the RA signaling
pathway in developing lungs.2. Materials and methods2.1. Animal model
This study was performed in accordance with the guidelines
provided by the Animal Care Use Committee of Taipei Medical
University, Taipei, Taiwan. Time-dated pregnant Spra-
gueeDawley rats were housed in individual cages with a
12:12-hour lightedark cycle and ad libitum access tolaboratory food and water. On Gestation Day 18, either ute-
roplacental insufficiency was induced through bilateral
uterine vessel ligation (IUGR group) or sham surgery was
performed (control group). All rats were delivered naturally
at term (22 days). Litters were separated from their mothers
within 12 hours of birth, pooled, and randomly redistributed
to the newly delivered mothers. Lung development occurs
over the embryonic, pseudoglandular, canalicular, saccular,
and alveolar stages; rats are born at the saccular stage,which
is equivalent to an approximately 30-week human gesta-
tion.15 Murine alveolar development begins on Postnatal Day
4, which is equivalent to the human alveolar stage. On Post-
natal Day 3 and Postnatal Day 7, rats were randomly selected
for examination from each group, irrespective of sex.
2.2. Histological analysis
Lung morphometry, examined using point counting through
light microscopy, has indicated that a proportion of the
parenchyma is highly constant in all lobes.16 The right lung
lobes were sectioned at 5 mm and stained with hematoxylin
and eosin, and digitized images of these lung sections were
captured in 20 nonoverlapping fields. Images were printed
and examined at a final magnification of 400.17 The
number of points along the alveolar airspace and alveolar
walls were counted by superimposing 49-point transparent
grids onto enlarged printed images. The alveoli were
defined as structures opening into alveolar ducts trans-
versely and enclosed by the respiratory epithelium cross-
sectionally. The volume fraction was calculated as Pi/Pt,
where Pi indicates the number of test points hitting the
structure of interest and Pt indicates the total number of
points hitting the reference space.
2.3. Western blotting
Lung tissues were homogenized in 1 mL of ice-cold lysis
buffer and centrifuged at 13,000 g for 20 minutes at 4C;
the supernatant was then aliquoted and stored at 20C.
After blocking with 5% nonfat skim milk, the membranes
were incubated with polyclonal RAR-a (C-20), RAR-b (C-19),
and RAR-g (G-1) antibodies (1:1000; Santa Cruz Biotech-
nology, Santa Cruz, CA, USA), and CRABP-1 (ab2816) and
CRABP-2 (ab74365) antibodies (1:1000; Abcam, Cambridge,
MA, USA); b-actin rabbit monoclonal antibody (1:5000; Cell
Signaling Technology, Danvers, MA, USA) was used as an
internal control. As secondary antibodies, goat antimouse
(#31320) and goat antirabbit (#31460) immunoglobulin
Gehorseradish peroxidase antibodies (1:10000; Pierce
Biotechnology Inc., Rockford, IL, USA) were used. The
densitometry unit of protein expression in the control group
was assigned as 1 after normalizing with b-actin.
Figure 1 Survival rates of control (open symbols) and intra-
uterine growth retardation (IUGR; closed symbols) rats. All
control rats survived throughout the study period. Uteropla-
cental insufficiency decreased survival rate of IUGR rats; the
rate reached 63% on Postnatal Day 3. * p< 0.001 versus control
rats.
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Immunostaining was performed on the 5-mm thick paraffin
sections, followed by immunoperoxidase visualization. After
endogenous peroxidase activity, the nonspecific binding of
antibodies were blocked and the sections were first pre-
incubated for 1 hour at room temperature in 0.1M phosphate-
buffered saline containing 10% normal goat serum and 0.3%
H2O2 and then incubated for 20 hours at 4
C with rabbit poly-
clonal anti-RAR-a and anti-RAR-b (1:50; Santa Cruz Biotech-
nology Inc., Dallas, TX, USA) and anti-RAR-g (1:100; Biorbyt
LLC, San Francisco, CA, USA) primary antibodies. The sections
were then treated for 1 hour at room temperature with bio-
tinylated goat antirabbiteimmunoglobulin G (1:100; Jackson
ImmunoResearch Laboratories Inc., West Grove, PA, USA),
followedbya reactionwiththereagents fromanavidinebiotin
complex kit (Vector, Torrance, CA, USA) following the manu-
facturer’s recommendations.Aminimumofthreerandomlung
fields of the immunohistochemically stained sections per ani-
mal were captured at 400magnification using a digital cam-
era. The images were imported into a computerized image
analysis system, Image-Pro Plus 5.1 (Media Cybernetics, Silver
Spring,MD,USA).Anautomaticobjectcountingandmeasuring
process was used to quantify the immunoreactivity in the
sections. We used the count/size function command to
perform the cell number counting operation. This generated a
percentage of positively stained cells, the values of which are
expressed as the labeling index (%).
2.5. Statistical analysis
Data are expressed as the means standard deviation.
Between-groups comparisons on each postnatal day were
evaluated using the Student t test. Survival rates were
evaluated using the KaplaneMeier method, and the log-
rank test was used for comparisons between study groups.
Differences were considered significant at p< 0.05.
3. Results
In total, 25 control and38 IUGRrats fromthree sham-operated
and five uteroplacental insufficiency-induced dams were
included in this study, respectively. The birth body weights of
the IUGR rats (5.95 0.76 g) were significantly lower than
those of the control rats (6.58 0.33 g; p< 0.001).
3.1. Survival
All control rats survived throughout the study period
(Figure 1). The survival rates of the IUGR rats decreased
significantly over the study period, reaching 63% on Post-
natal Day 3.
3.2. Body and lung weights and lung-to-body weight
ratios
Compared with the control rats, the IUGR rats exhibited
significantly lower body weights on Postnatal Day 3 and
Postnatal Day 7 and significantly lower lung weights on
Postnatal Day 3 (Table 1). The lung-to-body weight ratiosbetween the control and IUGR rats were comparable on
Postnatal Day 3 and Postnatal Day 7.
3.3. Western blotting
The IUGR rats showed significantly higher RAR-b expression
than the control rats did on Postnatal Day 3, but not on
Postnatal Day 7 (Figure 2B). The expression of RAR-a, RAR-
g, CRABP-1, and CRABP-2 between the control and IUGR
rats was comparable on Postnatal Day 3 and Postnatal Day 7
(Figures 2A and 2CeE).
3.4. Immunohistochemistry
RAR immunoreactivity was majorly detected in the nuclei of
bronchiolar epithelial cells and weakly detected in the
endothelial and type I cells (Figure 3: brown indicates posi-
tive staining for RAR). The IUGR rats exhibited significantly
higher RAR-b immunoreactivity than the control rats did on
Postnatal Day 3, but not on Postnatal Day 7. On Postnatal Day
3 and Postnatal Day 7, the immunoreactivities of RAR-a and
RAR-g between control and IUGR rats were comparable.
3.5. Histology
Figure 4A illustrates the light micrographs of the lung sec-
tions stainedwith hematoxylin and eosin. Comparedwith the
control rats, the IUGR rats exhibited a significantly higher
volume fraction of alveolar airspace on Postnatal Day 3 and
Postnatal Day 7 and a significantly lower volume fraction of
alveolar walls on Postnatal Day 3 (Figure 4B). On Postnatal
Day 7, the IUGR rats tended to exhibit a lower volume frac-
tion of alveolar walls than did the control rats (pZ 0.08).
4. Discussion
We found that uteroplacental insufficiency on Gestation Day
18reducedtheneonatalbodyand lungweightsof theoffspring
on Postnatal Day 3 and Postnatal Day 7. Similar to previous
Table 1 Body weight, lung weight, and lung-to-body weight ratios of the control and intrauterine growth retardation (IUGR)
rats on Postnatal Day 3 and Postnatal Day 7.
Treatment Postnatal d n Body weight (g) Lung weight (g) Lung-to-body weight ratio (%)
Control 3 12 9.43 1.23 0.17 0.02 1.88 0.16
IUGR 3 11 7.19 1.09** 0.14 0.03* 1.87 0.15
Control 7 13 16.13 2.31 0.29 0.04 1.80 0.10
IUGR 7 12 12.78 0.85** 0.25 0.05 1.96 0.26
Data are presented as mean standard deviation.
* p< 0.01 versus control group.
** p< 0.001 versus control group.
Figure 2 Western blotting. (A) retinoic acid receptors (RAR)-a; (B) RAR-b; (C) RAR-g; (D) cellular RA-binding protein (CRABP)-1;
and (E) CRABP-2. Intrauterine growth retardation (IUGR) rats had significantly higher RAR-b expression compared with the control
rats on Postnatal Day 3. The expression of RAR-a, RAR-g, CRABP-1, and CRABP-2 between the control and IUGR rats was comparable
on Postnatal Day 3 and Postnatal Day 7. Mean standard deviation. * p< 0.05 versus control rats on Postnatal Day 3.
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Figure 3 (A) Immunohistochemistry analysis of retinoic acid receptors (RAR)-a, RAR-b, and RAR-g immunoreactivity in control
and intrauterine growth retardation (IUGR) rats; (B) semiquantitative analysis of RAR-a, RAR-b, and RAR-g immunoreactivity in
control and IUGR rats. RAR immunoreactivity was majorly detected in the nuclei of bronchiolar epithelial cells (arrow) and weakly
detected in the endothelial cells (arrowhead) and type I cells. Brown indicates positive staining. IUGR rats exhibited significantly
higher RAR-b immunoreactivity compared with the control rats on Postnatal Day 3. The immunoreactivities of RAR-a and RAR-g
between the control and IUGR rats were comparable on Postnatal Day 3 and Postnatal Day 7.
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insufficiency during late gestation had decreased body
weights compared with the sham-operated newborn control
rats. The differences in lung weight were nonsignificant on
Postnatal Day 7. In other words, the greatest effects of ute-
roplacental insufficiency occur during the immediate post-
natal period, which is equivalent to the human alveolar stage
of lung development. Regarding clinical implications, utero-
placental insufficiency in humans may result in enlarged
alveoli and thickened septa in the lung parenchyma.
Regarding the histological changes in newborn rats
exposed to uteroplacental insufficiency, our model showed
a significant increase in the volume fraction of alveolar
airspace and a significant decrease in the volume fraction
of the alveolar walls on Postnatal Day 3 and Postnatal Day
7. This is consistent with defective alveolarization in
newborn rats exposed to uteroplacental insufficiency dur-
ing lung development.18 These results indicate that imma-
ture lungs may be sensitive to the effects of uteroplacental
insufficiency. In the present study, histological abnormal-
ities were associated with increased RAR-b expression in
the lung tissues of newborn rats exposed to uteroplacental
insufficiency during lung development. The time points
examined in this study encompassed the beginning stages of
rapid alveolarization in rats, where retinoids are critical
mediators.10e12 These histological abnormalities were most
and least significant on Postnatal Day 3 and Postnatal Day 7,
respectively. These data suggest that the effects of
developmental exposure to uteroplacental insufficiency are
greatest during the postnatal period of lung maturation.
RA binds to CRABP for intracellular transport to the nu-
cleus. The expression of RAR-a, RAR-b, and RAR-g isoformschanges during alveolarization.20 However, the alveolariza-
tion functions of the retinoids are complex. In this study, we
observed increased RAR-b expression in IUGR rat lungs on
Postnatal Day 3, which is consistent with previous findings
that RAR-a and RAR-g promote alveolar formation, whereas
RAR-b inhibits it.11,12,18,21,22 Grummer and Zachman23
revealed that RAR family members exhibit differential gene
expression profiles from prenatal and postnatal periods to
adulthood, suggesting that each RAR isoform has a specific
function during the alveolarization period in rat lungs. Thus,
exposure to uteroplacental insufficiency during late gesta-
tion may disrupt the highly regulated process and support
normal alveolarization, which requires a precise regulation
of retinoid kinetics and abundance.11,20,24
Our animal model has several limitations. Firstly, we did
not measure retinol concentrations in the serum or retinyl
ester concentrations in the lungs. Nevertheless, Joss-Moore
et al18 demonstrated that IUGR does not affect serum retinol
concentrations in a similar animal model; in contrast to our
study, the authors induced uteroplacental insufficiency on
Gestation Day 19 and found that IUGR resulted in sex-specific
differences in lung RAR protein isoform abundance. Sec-
ondly, RA is a constituent of one of the nutritional systems
that can affect alveolar development;25 hence, the retinoid
pathway may also be only one of the pathways mediating
lung abnormalities caused by uteroplacental insufficiency.5. Conclusions
Our data show that uteroplacental insufficiency causes
defective alveolarization and transiently increases RAR-b
Figure 4 (A) Representative histology; (B) alveolar airspace and alveolar wall volume fractions of control and intrauterine growth
retardation (IUGR) rat lungs. Compared with the control rats, the IUGR rats exhibited a significantly higher volume fraction of
alveolar airspace on Postnatal Day 3 and Postnatal Day 7 and a significantly lower volume fraction of the alveolar walls on Postnatal
Day 3. On Postnatal Day 7, the IUGR rats tended to exhibit a significantly lower volume fraction of alveolar walls than the control
rats did (pZ 0.08). Data are presented as mean standard deviation. * p< 0.05 versus control rats at each time point.
Uteroplacental insufficiency and retinoid pathway 513expression in the lungs of newborn rats. The increases are the
most prominent immediately before rapid alveolarization
onset on around Postnatal Day 3. Thus, we suggest that
altered retinoid pathway activitymay be amechanism of lung
abnormalities causedbyuteroplacental insufficiency andmay
represent a therapeutic target for IUGR in neonates.
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